Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Remote ischaemic preconditioning to reduce myocardial complications following head and neck cancer surgery
ISRCTN ISRCTN82938832
ClinicalTrials.gov identifier
Public title Remote ischaemic preconditioning to reduce myocardial complications following head and neck cancer surgery
Scientific title A prospective double-blind randomised controlled trial of the impact of remote-organ ischaemic preconditioning on perioperative myocardial morbidity and postoperative complications in head and neck surgery: Myocardial Event Reduction with Ischaemic-preconditioning Therapy (MERIT)
Acronym MERIT
Serial number at source 10/H0801/2
Study hypothesis Does remote ischaemic preconditioning reduce the incidence of myocardial damage associated with major head and neck surgery? As a secondary hypothesis, does remote ischaemic preconditioning reduce the degree of post-operative inflammation, the number and severity of post-operative complications, length of critical care stay, and the overall duration of hospitalisation?
Lay summary
Ethics approval Royal Marsden Research Ethics Committee approved on the 2nd February 2010 (ref: 10/H0801/2)
Study design Double-blind randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Squamous cell carcinoma of the upper aerodigestive tract
Participants - inclusion criteria 1. Patients aged under 90 years, either sex
2. Squamous cell carcinoma of the upper aerodigestive tract (head and neck cancer)
3. Undergoing excision of the primary site tumour and removal of cervical lymph nodes as part of the management of their condition
Participants - exclusion criteria 1. Patients over 90 years of age
2. Patients unable to give informed consent
3. Patients unfit to undergo general anaesthesia
4. Patients undergoing only neck dissection surgery
5. Patients with non-squamous cell carcinoma pathology
6. Patients undergoing excision of tumours of the skull base
7. Diabetic patients taking sulphonylurea medications
8. Patients taking nicorandil
9. Patients undergoing trans-oral laser resection of tumours
10. Patients with a previous history of deep-vein thrombosis or pulmonary embolism
11. Patients with known peripheral vascular disease who have an Ankle-Brachial Pressure Index less than 0.7)
Anticipated start date 05/08/2010
Anticipated end date 05/08/2012
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 92
Interventions The intervention group will receive remote ischaemic preconditioning which will be achieved immediately after induction of anaesthesia using an orthopaedic lower limb tourniquet inflated to 50 mmHg above the systolic pressure for two cycles of five minutes, interleaved with a single seven-minute period of reperfusion.

The control group will not have remote ischaemic preconditioning; they will have a lower limb torniquet placed around their leg but this will not be inflated.

The duration of treatment is 20 minutes and the follow-up is six months.
Primary outcome measure(s) Incidence of myocardial injury following head and neck surgery, as measured by the level of cardiac troponin enzyme at days 1, 3 and 7 after the operation.
Secondary outcome measure(s) 1. The rate of rise of C-reactive protein levels in the post-operative period (the inflammatory gradient)
2. Incidence and severity of post-operative complications as graded on a validated complications grading system
3. Length of stay in the Intensive Care, High-dependency and ward
4. Patient weight and swallowing status during follow-up
5. One-year MACE (Major Acute Cardiovascular Event) rate
Sources of funding Imperial College Healthcare NHS Trust (UK)
Trial website http://www.scientificsurgery.co.uk/merit-trial
Publications
Contact name Dr  Patrick  Doyle
  Address Department of Anaesthesia
Imperial College Healthcare NHS Trust
Charing Cross Hospital
  City/town London
  Zip/Postcode W6 8RF
  Country United Kingdom
  Email patrick.doyle@imperial.nhs.uk
Sponsor Imperial College Healthcare NHS Trust (UK)
  Address c/o Michelle Quaye
The Joint Research Office
Hammersmith Hospital
Du Cane Road
  City/town London
  Zip/Postcode W14 0HS
  Country United Kingdom
  Sponsor website: http://www.imperial.nhs.uk/
Date applied 07/07/2010
Last edited 29/07/2010
Date ISRCTN assigned 29/07/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central